| Alejandro Saranglao Jr, MD | |
|
248 Pleasant St, Suite G100, Concord, NH 03301-2588 | |
| (603) 224-9661 | |
| (603) 228-7051 |
| Full Name | Alejandro Saranglao Jr |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 248 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104868082 | NPI | - | NPPES |
| AA16415 | Other | NH | HARVARD PILGRIM |
| 30204448 | Medicaid | NH | |
| P00169515 | Other | NH | RAIL ROAD MEDICARE |
| 386552 | Other | NH | MVP HEALTH CARE (INT. MED |
| 386553 | Other | NH | MVP HEALTH CARE (CRITICAL |
| 386554 | Other | NH | MVP HEALTH CARE (PULM CAR |
| 1104868082 | Other | NH | ANTHEM BLUE CROSS |
| 7794663 | Other | NH | AETNA |
| 414210099 | Medicaid | ME |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 12176 (New Hampshire) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 12176 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Hospital Inc | 6103721790 | 462 |
News Archive
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Advanced Medical Pricing Solutions and TC3 Health, Inc. recently announced an affiliate partnership to expand the healthcare cost containment offerings of both companies. TC3 is the premier provider of fraud, waste and abuse detection services for healthcare payers throughout the United States. Since 2000, TC3 has provided integrated loss control solutions to health care payers on a pre-payment and post-payment basis through its TruClaim Payment Integrity Platform.
Researchers at The Ohio State University Wexner Medical Center have shown that patients who have chronic pain can reduce their emotional response to the pain through spinal cord stimulation.
The NCCN Clinical Practice Guidelines in Oncology have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines™ are being translated into Japanese. The Translational Research Informatics Center Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer of the Colon and Rectum, has translated the NCCN Guidelines for Colon Cancer and Rectal Cancer, which are now available online.
› Verified 3 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Advanced Medical Pricing Solutions and TC3 Health, Inc. recently announced an affiliate partnership to expand the healthcare cost containment offerings of both companies. TC3 is the premier provider of fraud, waste and abuse detection services for healthcare payers throughout the United States. Since 2000, TC3 has provided integrated loss control solutions to health care payers on a pre-payment and post-payment basis through its TruClaim Payment Integrity Platform.
Researchers at The Ohio State University Wexner Medical Center have shown that patients who have chronic pain can reduce their emotional response to the pain through spinal cord stimulation.
The NCCN Clinical Practice Guidelines in Oncology have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines™ are being translated into Japanese. The Translational Research Informatics Center Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer of the Colon and Rectum, has translated the NCCN Guidelines for Colon Cancer and Rectal Cancer, which are now available online.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alejandro Saranglao Jr, MD 248 Pleasant Street, Suite G100, Concord, NH 03301-2526 Ph: (603) 224-9661 | Alejandro Saranglao Jr, MD 248 Pleasant St, Suite G100, Concord, NH 03301-2588 Ph: (603) 224-9661 |
News Archive
The protocol used to treat the first known survivor of rabies without prior vaccination is published in the June 16, 2005, issue of the New England Journal of Medicine. It is hoped that this approach can be replicated, tested, and provide a guide for treating this fatal condition, especially in parts of the world where the incidence of rabies is rampant.
Janssen Research & Development, LLC (JRD) announced today that the U.S. Food and Drug Administration (FDA) has assigned a Priority Review designation to the supplemental New Drug Application (sNDA) filed on December 29, 2011 for XARELTO (rivaroxaban), an oral anticoagulant, to reduce the risk of thrombotic cardiovascular events in patients with Acute Coronary Syndrome (ACS).
Advanced Medical Pricing Solutions and TC3 Health, Inc. recently announced an affiliate partnership to expand the healthcare cost containment offerings of both companies. TC3 is the premier provider of fraud, waste and abuse detection services for healthcare payers throughout the United States. Since 2000, TC3 has provided integrated loss control solutions to health care payers on a pre-payment and post-payment basis through its TruClaim Payment Integrity Platform.
Researchers at The Ohio State University Wexner Medical Center have shown that patients who have chronic pain can reduce their emotional response to the pain through spinal cord stimulation.
The NCCN Clinical Practice Guidelines in Oncology have been further recognized as the global standard in oncology with the announcement that select NCCN Guidelines™ are being translated into Japanese. The Translational Research Informatics Center Foundation for Biomedical Research and Innovation, under the supervision of the Japanese Society for Cancer of the Colon and Rectum, has translated the NCCN Guidelines for Colon Cancer and Rectal Cancer, which are now available online.
› Verified 3 days ago
Patrick Cassell, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6994 | |
Dr. Michael A Ferguson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Clayton Theron Jones, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant St, Suite 103, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. David Scott Johnson, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Primary Care, Concord, NH 03301 Phone: 603-226-2200 | |
Frederick M Briccetti, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant Street, New Hampshire Oncology Hematology Pa, Concord, NH 03301 Phone: 603-224-2556 Fax: 603-226-5821 | |
Dr. Patrick Magnus, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 246 Pleasant Street Memorial Building, West, Ground Flo, Concord, NH 03301 Phone: 603-224-6070 Fax: 603-224-6094 | |
Dr. Celia Ann Englander, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 281 N State St, Concord, NH 03301 Phone: 603-271-6064 |